Enveda CEO Viswa Colluru on the Mission to Decode Nature's Pharmacy
Inside the ICE House
•
18m
Enveda Biosciences is using AI to decode nature’s vast chemical library and transform it into breakthrough medicines. Founded in 2019 by Viswa Colluru, the company is advancing first-in-class therapies like ENV-294 while cutting the time and cost of drug discovery. Colluru joins Inside the ICE House to share how Enveda is reimagining the playbook for modern medicine and building a healthier future for patients worldwide.
Up Next in Inside the ICE House
-
David McCormick's Battleplan for a "S...
David McCormick, author of SUPERPOWER IN PERIL: A Battle Plan to Renew America, has spent his life at the nexus of Wall Street, Main Street, and Government. His book combines lessons learned leading soldiers as a West Point Graduate and leading businesses, among them Bridgewater Associates, where...
-
Virtu's Vinnie Viola, on his Journey ...
Vincent Viola, Founder and Chairman Emeritus of Virtu Financial, is a son of Brooklyn, a cadet of West Point, a brother of the NYMEX trading pits, and now an owner of Panthers and winner of the Prince of Wales Trophy. Vinnie’s NHL hockey team fell short of the Stanley Cup in 2023, but his team fr...
-
Nimbus CEO Abbas Kazimi on Leading th...
Nimbus Therapeutics is transforming drug discovery with computational chemistry and AI to design small molecules that precisely target disease. CEO Abbas Kazimi, who took the helm in March, is driving a “fail fast” approach that balances discipline with innovation. He joins Inside the ICE House t...
